Medicenna is pleased to announce that all nominees listed in the management information circular dated August 13, 2025 (the “Circular”), were elected as directors. The results of the vote are detailed ...

Tiziana said that TZLS-501 may offer therapeutic advantages in managing acute and chronic inflammatory conditions.

Nasdaq-listed shares of Tiziana Life Sciences (TLSA) rose 2% by Thursday afternoon after the company announced that it will ...

Neuroinflammation is linked to a host of detrimental brain disorders, including Alzheimer's and Parkinson's disease.

Neuroinflammation is linked to a host of detrimental brain disorders, including Alzheimer's and Parkinson's disease. A ...

A nonbiologic oral IL-23 inhibitor is more effective and safer than an approved oral JAK inhibitor for moderate-to-severe ...

TZLS-501 is a fully human anti-IL-6 receptor (“IL-6R”) monoclonal antibody (mAb) targeting both the membrane-bound and soluble forms of IL-6R. This dual mechanism of action not only blocks IL-6R ...

Greek yogurt supplementation post-training significantly reduces inflammation markers in young males, offering insights into ...

Among adults with obesity who lost weight after following a low-calorie diet, weight-loss maintenance with exercise was ...

India - Grant Romiplostim Lyophilized Formulations Patent With Amendments: Madras High Court Directs. Legal News and Analysis ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

The EMA’s recommendation marks a key step toward expanding treatment access for patients with psoriasis, psoriatic arthritis, ...